MCF Advisors’s Edwards Lifesciences EW Stock Holding History

MCF Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.1K	Sell	364 -207	-36%	-$17.1K	﹤0.01%	724
2025 Q4	$48.7K	Buy	571 +207	+57%	+$17K	﹤0.01%	520
2025 Q3	$28.3K	Hold	364	–	–	﹤0.01%	514
2025 Q2	$28.5K	Hold	364	–	–	﹤0.01%	490
2025 Q1	$26.4K	Sell	364 -24	-6%	-$1.72K	﹤0.01%	495
2024 Q4	$28.7K	Sell	388 -3	-0.8%	-$210	﹤0.01%	484
2024 Q3	$25.8K	Sell	391 -67	-15%	-$4.87K	﹤0.01%	495
2024 Q2	$42.3K	Buy	458 +58	+15%	+$5.14K	﹤0.01%	414
2024 Q1	$38.2K	Buy	400 +3	+0.8%	+$252	﹤0.01%	420
2023 Q4	$30.3K	Sell	397 -14	-3%	-$974	﹤0.01%	445
2023 Q3	$28.5K	Hold	411	–	–	﹤0.01%	434
2023 Q2	$38.8K	Hold	411	–	–	﹤0.01%	392
2023 Q1	$34K	Buy	411 +264	+180%	+$20.8K	﹤0.01%	409
2022 Q4	$11K	Buy	147 +14	+11%	+$1.08K	﹤0.01%	523
2022 Q3	$11K	Hold	133	–	–	﹤0.01%	538
2022 Q2	$13K	Hold	133	–	–	﹤0.01%	487
2022 Q1	$16K	Buy	+133	New	+$14.9K	﹤0.01%	481
2021 Q4	–	Sell	-133	Closed	-$15K	–	246
2021 Q3	$15K	Buy	133 +33	+33%	+$3.77K	﹤0.01%	442
2021 Q2	$10K	Hold	100	–	–	﹤0.01%	447
2021 Q1	$8K	Hold	100	–	–	﹤0.01%	430
2020 Q4	$9K	Hold	100	–	–	﹤0.01%	389
2020 Q3	$8K	Buy	+100	New	+$7.8K	﹤0.01%	395

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

MCF Advisors's EW Position: Q1 2026 in Review

MCF Advisors reduced its Edwards Lifesciences (EW) stake by 36% in Q1 2026, selling an estimated $17.1K and leaving 364 shares worth $29.1K. The position accounts for ﹤0.01% of the portfolio, ranked #724.

MCF Advisors first reported a position in EW in Q3 2020 and has held it in 22 quarters since. The position peaked at $48.7K in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

MCF Advisors held 364 shares of Edwards Lifesciences worth $29.1K as of Q1 2026.
MCF Advisors sold 207 Edwards Lifesciences shares in Q1 2026, an estimated $17.1K.
Edwards Lifesciences made up ﹤0.01% of MCF Advisors's portfolio in Q1 2026, its #724 holding.
MCF Advisors first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 22 quarters since.
MCF Advisors's Edwards Lifesciences position peaked at $48.7K in Q4 2025.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.